Smiths acquires biotechnology company
EDGEWOOD, Md.--Smiths Group plc announced in mid-May that it has entered into a definitive agreement to acquire ETI Technology, Inc., a privately owned company that developed sensors for the detection of harmful biological agents, for $4 million in cash.
ETI's optical sensors perform an initial screening of bio agents to provide analysis and classification, and permit rapid deployment of biological detectors. The technology will be employed to reduce operational costs for conventional detectors made by Smiths Detection, including equipment to identify biological agents used by military forces, emergency response teams and in critical infrastructure applications.
The acquisition of ETI further broadens the technology base within the company.
Earlier this year, it announced the acquisition of Farran Technology Ltd., which is developing millimeter wave screening to detect hidden weapons and explosives for applications in transportation security.